Meinuo: Subsidiary Lorazepam Hydrochloride API Receives Approval Notice for Market Application

Meinuohua announced on the evening of August 4th that its subsidiary Anhui Meinuohua Pharmaceutical Chemical Co., Ltd. recently received the approved issuance from the National Medical Products Administration for the marketing application of Risperidone Hydrochloride raw material drug. Indications: Used for the treatment of schizophrenia.